natgillin/translations-raw huggingface dataset:
Hypersensitivity reactions with immediate (e.g. anaphylaxis) and delayed onset (e.g. serum sickness) have been reported in patients treated with Gazyvaro.
(npr. anafilaksija) i one s odgođenim nastupom (npr. serumska bolest).
· Tell your doctor or nurse straight away if you have memory loss, trouble speaking, difficulty walking or problems with your eyesight.
· Odmah obavijestite svog liječnika ili medicinsku sestru ako primijetite gubitak pamćenja,
Musculoskeletal chest pain, pain in extremity, bone pain
mišićno-koštana bol u prsištu, bol u kostima
Squamous cell carcinoma of skin Squamous cell carcinoma of skin Blood and lymphatic system disorders Very common
Poremećaji krvi i limfnog sustava vrlo često neutropenija§, trombocitopenija, anemija, leukopenija neutropenija, trombocitopenija često bol u limfnom čvoru anemija, leukopenija
IRC: Independent Review Committee; PFS: progression-free survival; HR: Hazard Ratio; CI: Confidence Intervals, NR = Not Reached # Patients with FL who did not respond or who progressed during or up to 6 months after treatment with rituximab or a rituximab-containing regimen *Stratification factors for analysis were refractory type (rituximab monotherapy vs. rituximab + chemotherapy) and prior therapies (≤ 2 vs > 2).
Bolesnici s FL-om koji nisu odgovorili na liječenje rituksimabom ili protokolom koji sadrži rituksimab, ili su doživjeli progresiju tijekom ili do 6 mjeseci nakon takvog liječenja *Stratifikacijski čimbenici za analizu bili su refraktornost (refraktorni na monoterapiju rituksimabom naspram refraktornih na rituksimab + kemoterapiju) i prethodne terapije (≤ 2 naspram > 2).
GAO4753g/GADOLIN) that occurred at a higher incidence (difference of ≥ 2%) compared to the relevant comparator arm in at least one pivotal study in: · Patients with CLL receiving Gazyvaro plus chlorambucil compared with chlorambucil alone or rituximab plus chlorambucil (study BO21004/CLL11) · Patients with previously untreated iNHL receiving Gazyvaro plus chemotherapy (bendamustine, CHOP, CVP) followed by Gazyvaro maintenance in patients achieving a response, compared to rituximab plus chemotherapy followed by rituximab maintenance in patients achieving a response (study BO21223/GALLIUM) · Patients with iNHL who had no response to or who progressed during or up to 6 months after treatment with rituximab or a rituximab-containing regimen receiving Gazyvaro plus bendamustine, followed by Gazyvaro maintenance in some patients, compared to bendamustine alone (study GAO4753g/GADOLIN) The incidences presented in Table 6 (all grades and Grades 3-5) are the highest incidence of that ADR reported from any of the three studies.
(bendamustin, CHOP, CVP), nakon čega je u bolesnika koji su ostvarili odgovor uslijedila terapija održavanja lijekom Gazyvaro, nego u bolesnika liječenih rituksimabom plus kemoterapijom, nakon čega je u bolesnika koji su ostvarili odgovor uslijedila terapija održavanja rituksimabom (ispitivanje BO21223/GALLIUM)
Gazyvaro in combination with bendamustine followed by Gazyvaro maintenance is indicated for the treatment of patients with FL who did not respond or who progressed during or up to 6 months after treatment with rituximab or a rituximab-containing regimen.
indiciran za liječenje bolesnika s FL-om koji nisu odgovorili na liječenje rituksimabom ili protokolom koji sadrži rituksimab, ili su doživjeli progresiju tijekom ili do 6 mjeseci nakon takvog liječenja.
These include: · fever · cough · chest pain · fatigue · painful rash · sore throat · burning pain when passing urine · feeling weak or generally unwell
· žareću bol pri mokrenju · slabost ili opće loše osjećanje
Common
ND
Water for injections
· vrućica · plućna infekcija
The subgroups evaluated included IPI, FLIPI, Bulky Disease, B Symptoms at baseline, Ann Arbor Stage and ECOG at baseline.
Prognostic Index, IPI), indeksu FLIPI, velikoj tumorskoj masi, B-simptomima na početku ispitivanja,
Molecular remission at end of treatmentd No. of patients included in the analysis MRD negativee (%)
Stabilna bolest (%) Trajanje odgovora (prema ocjeni neovisnog ocjenjivačkog povjerenstva) Broj bolesnika uključenih u analizu Broj (%) bolesnika s događajem
Neoplasms benign, malignant and unspecified (incl cysts and polyps) Common
Dobroćudne, zloćudne i nespecificirane novotvorine (uključujući ciste i polipe) često planocelularni karcinom kože planocelularni karcinom kože
Most frequently reported: · nausea · fatigue · dizziness · headache · diarrhoea · fever, flushing or chills · vomiting · shortness of breath · low or high blood pressure · heart beating very fast · chest discomfort
Poremećaji probavnog sustava vrlo često proljev, konstipacija često dispepsija, kolitis, hemoroidi proljev, kolitis manje često konstipacija, hemoroidi
Haemorrhagic events and Grade 3-5 haemorrhagic events occurred in 12% and 5% of patients, respectively.
Događaji krvarenja javili su se u 12% bolesnika, a događaji krvarenja 3. - 5. stupnja u 5% bolesnika.
Metabolism and nutrition disorders Common
Trombocitopenija i događaji krvarenja
Median was not reached at time of analysis # not adjusted for multiplicity **Assessed as per modified Cheson 2007 criteria ‡ End of Induction = end of induction phase, does not include monotherapy maintenance
**Ocijenjeno prema modificiranim Chesonovim kriterijima iz 2007.
Inhalation Powder, Hard Capsule
Prašak inhalata, tvrda kapsula
Novartis Poland Sp. Z O. O.
Novartis Poland Sp. Z O.
Pressurised Inhalation, Suspension
Stlačeni inhalat, suspenzija
Smithkline Beecham Farma S.A.
Španjolska Smithkline Beecham Farma S.A.
Ucb Pharma Gmbh (Monheim De)
Njemačka Ucb Pharma Gmbh (Monheim De)
Astrazeneca Farmacéutica Spain, S.A.
Španjolska Astrazeneca Farmacéutica Spain, S.A.
Netherlands Chiesi Pharmaceuticals B.V.
Nizozemska Chiesi Pharmaceuticals B.V.
Janssen-Cilag Gmbh
Njemačka Janssen-Cilag Gmbh
Clenil Compositum Beclometasone Dipropionate 0.8mg/2 Ml, Salbutamol Sulfate 1.928mg/2 Ml
Clenil Compositum Beklometazon dipropionat 0,8 mg/2 Ml, salbutamol sulfat 1,928 mg/2 Ml
Flunisolide 25mg Bottle, Salbutamol 10mg Bottle
Flunisolid 25 mg boca, salbutamol 10 mg boca
Netherlands Astrazeneca Bv
Nizozemska Astrazeneca Bv
Medochemie Romania S.R.L.
Rumunjska Medochemie Romania S.R.L.
Budesonide 200µg Capsule
Budezonid 200 µg kapsula
Salmeterol/Flutikazonpropio nat Diskus Glaxosmithkline
Salmeterol/Flutikazonpro pionat Diskus Glaxosmithkline
Allen Farmaceutica, S.A.
Španjolska Allen Farmaceutica, S.A.
Formoterol Fumarate Dihydrate 1,08 Mg, Beclometasone Dipropionate 18 Mg
Formoterol fumarat dihidrat 1,08 Mg, beklometazon dipropionat 18 Mg
Astrazeneca France
Francuska Astrazeneca France
Budesonide 0,92 Mg
Budezonid 0,92 Mg
Fluticasone Propionate 2mg/2ml
Flutikazon propionat 2 mg/2 ml
Mylan Dura Gmbh
Njemačka Mylan Dura Gmbh
Ratiopharm Gmbh
Njemačka Ratiopharm Gmbh
Belgium Cipla Europe Nv
Cipla Europe
Budezonid Lek-Am Budesonide 400µg Inhalation
Budezonid Lek-Am Budezonid 400 µg inhalat
S.C. Sandoz S.R.L.
Rumunjska S.C. Sandoz S.R.L.
Luxembourg Elpen Pharmaceutical Co. Inc.
Luksemburg Elpen Pharmaceutical Co.
Budezonid Lek-Am Budesonide 200µg Inhalation
Budezonid Lek-Am Budezonid 200 µg inhalat
Budesonide 0.8mg Capsule
Cyclocaps Budesonid Budezonid 0,8 mg kapsula
Chiesi España, S.A.
Španjolska Chiesi España, S.A.
Clenil Compositum Beclometasone Dipropionate 50µg Actuation, Salbutamol Sulfate 120µg Actuation
Clenil Compositum Beklometazon dipropionat 50 µg po aktuaciji, salbutamol sulfat 120 µg po aktuaciji
Fluticasone Propionate 125µg Capsule Inhalation Powder, Hard Capsule
Flutikazon propionat 125 µg kapsula Prašak inhalata, tvrda kapsula
Almirall, S.A.
Španjolska Almirall, S.A.
Budesonide 1mg Ampoule
Budezonid 1 mg ampula
Netherlands Glaxosmithkline B.V.
Nizozemska Glaxosmithkline B.V.
Salbutamol Sulfate 0.602mg Vial, Flunisolide 0.5mg Vial
Salbutamol sulfat 0,602 mg bočica, flunisolid 0,5 mg bočica
Beclometasone Dipropionate 250µg/59.2 Mg
Beklometazon dipropionat 250 µg/59,2 Mg
Fluticasone Propionate 0.05mg/2ml
Flutikazon propionat 0,05 mg/2 ml
Laboratorio Tau, S.A.
Španjolska Laboratorio Tau, S.A.
Budosenide 320mcg, Formoterol Fumarate Dihydrate 9mcg
Budezonid 320 mcg, formoterol fumarat dihidrat 9 mcg
Fluticasone Propionate 500 Microgram, Salmeterol Xinafoate 50 Microgram
Flutikazon propionat 500 mikrograma, salmeterol ksinafoat 50 mikrograma
Chiesi S.A.
Francuska Chiesi S.A.
Beclometasone Dipropionate 50µg/50 µl
Beklometazon dipropionat 50 µg/50 µl
Budosenide 160mcg, Formoterol Fumarate Dihydrate 4.5mcg
Budezonid 160 mcg, formoterol fumarat dihidrat 4,5 mcg
Fluticasone Propionate 250mgg
Flutikazon propionat 250 mgg
Budesonide 0.2mg/0.05ml
Budezonid 0,2 mg/0,05 ml
Fluticasone Propionate 0,5 Mg, Salmeterol Xinafoate 0,073 Mg
Flutikazon propionat 0,5 Mg, salmeterol ksinafoat 0,073 Mg
Belgium Orion Corporation
Španjolska Orion Corporation
Fluticasone Propionate 0,25 Mg, Salmeterol Xinafoate 0,073 Mg
Flutikazon propionat 0,25 Mg, salmeterol ksinafoat 0,073 Mg
Budesonide 0.25mg Ampoule
Budezonid 0,25 mg ampula
Laboratoire Glaxosmithkline S.A.S.
Francuska Laboratoire Glaxosmithkline S.A.S.
Fluticasone Propionate 250µg Dose, Salmeterol 50µg Dose, Lactose Monohydrate 24.677mg Dose
Flutikazon propionat doza od 250 µg, salmeterol doza od 50 µg, laktoza monohidrat doza od 24,677 mg
Teva Gmbh
Njemačka Teva Gmbh
Budesonide 0,2 Mg
Budezonid 0,2 Mg
Fluticasone Propionate 500µg Dose, Salmeterol 50µg Dose, Lactose Monohydrate 24.677mg Dose
Flutikazon propionat doza od 500 µg, salmeterol doza od 50 µg, laktoza monohidrat doza od 24,677 mg
Astrazeneca Gmbh
Njemačka Astrazeneca Gmbh
Abz-Pharma Gmbh
Njemačka Abz-Pharma Gmbh
Netherlands Elpen Pharmaceutical Co. Inc.
Nizozemska Elpen Pharmaceutical Co.
Pb Pharma Gmbh
Njemačka Pb Pharma Gmbh
Beclometasone Dipropionate 100g/10ml
Beklometazon dipropionat 100 g/10 ml
Budesonide 400µg
Budezonid 400 µg
Chiesi Gmbh
Njemačka Chiesi Gmbh
Beclometasone Dipropionate 100µg/50 µl
Beklometazon dipropionat 100 µg/50 µl
Budesonide, Micronised 0.4mg Actuation
Budezonid, mikronizirani 0,4 mg po aktuaciji
Cyclocaps Beclometason Beclometasone Dipropionate 400µg Units
Cyclocaps Beclometason Beklometazon dipropionat 400 µg jedinice
Cyclocaps Beclometason Beclometasone Dipropionate 100µg Units
Cyclocaps Beclometason Beklometazon dipropionat 100 µg jedinice
Beclometasone Dipropionate 100µg Inhalation, Formoterol Fumarate 6µg Inhalation
Beklometazon dipropionat 100 µg inhalat, formoterol fumarat 6 µg inhalat
Fluticasone Propionate 500µg, Salmeterol Xinafoate 72,5µg
Flutikazon propionat 500 µg, salmeterol ksinafoat 72,5 µg
Budesonide 200µg
Budezonid 200 µg
Cyclocaps Beclometason Beclometasone Dipropionate 200µg Units
Cyclocaps Beclometason Beklometazon dipropionat 200 µg jedinice
Budesonide, Micronised 0.2mg Actuation
Budezonid, mikronizirani 0,2 mg po aktuaciji
Fluticasone Propionate 125µg Inhalation
Flutikazon propionat 125 µg inhalat
Budesonide 160µg Inhalation, Formoterol Fumarate Dihydrate 4.5µg Inhalation
Budezonid 160 µg inhalat, formoterol fumarat dihidrat 4,5 µg inhalat
Budesonide 0.5mg Ampoule
Budezonid 0,5 mg ampula
Belgium Pari Pharma Gmbh
Njemačka Pari Pharma Gmbh
Budesonide 320µg, Formoterol Fumarate Dihydrate 9µg
Budezonid 320 µg, formoterol fumarat dihidrat 9 µg
Budesonide 160µg, Formoterol Fumarate Dihydrate 4.5µg
Budezonid 160 µg, formoterol fumarat dihidrat 4,5 µg
Glaxosmithkline Export Ltd
Glaxosmithkline Export
Budesonide 800µg Units
Cyclocaps Budesonid Budezonid 800 µg jedinice
Beclometasone Dipropionate 100g/5ml
Beklometazon dipropionat 100 g/5 ml
Fluticasone Propionate 250µg Inhalation
Flutikazon propionat 250 µg inhalat
Budesonide 1,0 Mg
Pulmicort Budesonide Budezonid 1,0 Mg
Fluticasone Propionate 250mcg/Dose Inhalation Powder
Flutikazon propionat doza od 250 mcg Prašak inhalata
Budesonide 320µg Inhalation, Formoterol Fumarate Dihydrate 9µg Inhalation
Budezonid 320 µg inhalat, formoterol fumarat dihidrat 9 µg inhalat
Beclometasone Dipropionate 100µg Actuation, Formoterol Fumarate Dihydrate 6µg Dose
Beklometazon dipropionat 100 µg po aktuaciji, formoterol fumarat dihidrat doza od 6 µg
Formoterol Fumarate Dihydrate 6µg Dose, Beclometasone Dipropionate Anhydrous 100µg Dose
Formoterol fumarat dihidrat doza od 6 µg, beklometazon dipropionat bezvodni doza od 100 µg
Fluticasone Propionate 50µg Inhalation
Flutikazon propionat 50 µg inhalat
Fluticasone Propionate 125µg Dose Aerosol
Flutikazon propionat doza od 125 µg Aerosol
Budesonide 200µg Spray
Budezonid 200 µg sprej
Glaxosmithkline S.A.
Španjolska Glaxosmithkline S.A.
Budesonide 0.2mg Dose
Budezonid doza od 0,2 mg
Budesonide 400µg Inhalation
Budezonid 200 µg inhalacija
Budesonide 100µg Units
Cyclocaps Budesonid Budezonid 100 µg jedinice
Budesonide 320µg Dose, Formoterol Fumarate Dihydrate Ph.Eur.
Budezonid doza od 320 µg, formoterol fumarat dihidrat Ph.Eur. doza od 9 µg
Salmeterol 25µg/Dose; Fluticasone Propionate 125µg/Dose
Salmaterol doza od 25 µg; flutikazon propionat doza od 125 µg
Beclometasone Dipropionate 0.2mg Dose
Beklometazon dipropionat doza od 0,2 mg
Beclometasone Dipropionate 100µg Actuation, Formoterol Fumarate Dihydrate 6µg Actuation
Beklometazon dipropionat 100 µg po aktuaciji, formoterol fumarat dihidrat 6µg po aktuaciji
Fluticasone Propionate 250µg Dose Aerosol
Flutikazon propionat doza od 250 µg Aerosol
Budesonide, Micronised 400µg Dose Inhalation Powder
Budezonid, mikronizirani, doza od 400 µg
Fluticasone Propionate 250 Mcg Dose, Salmeterol Xinafoate 50 Mcg Dose
Flutikazon propionat doza od 250 Mcg, salmeterol ksinafoat doza od 50 Mcg
Beclometasone Dipropionate 0.2mg/18.7g
Beklometazon dipropionat 0,2 mg/18,7 g
Fluticasone Propionate 250mcg/Dose Pressurised Inhalation,
Flutikazon propionat doza od 250 mcg Stlačeni inhalat, suspenzija
Beclometasone Dipropionate 0.1mg/18.7g
Beklometazon dipropionat 0,1 mg/18,7 g
Fluticasone Propionate 100 Mcg Dose, Salmeterol Xinafoate 50 Mcg Dose
Flutikazon propionat doza od 100 Mcg, salmeterol ksinafoat doza od 50 Mcg
Fluticasone Propionate 500 Mcg Dose, Salmeterol Xinafoate 50 Mcg Dose
Flutikazon propionat doza od 500 Mcg, salmeterol ksinafoat doza od 50 Mcg
Fluticasone Propionate 250µg
Flutikazon propionat 250 µg sprej
Glaxosmithkline Gmbh & Co. Kg Viani Forte
Njemačka Glaxosmithkline Gmbh & Co.
Fluticasone Propionate 125µg Dose Pressurised Inhalation
Flutikazon propionat doza od 125 µg Stlačeni inhalat
Samtoral Diskus Standard Fluticasone Propionate 250µg Dose, Salmeterol 50µg Dose
Flutikazon propionat doza od 250 µg, salmeterol 50 µg
Salmeterol Xinafoate 50µg Dose, Fluticasone Propionate 250µg Dose
Salmeterol ksinafoat doza od 50 µg, flutikazon propionat doza od 250 µg
Beclometasone Dipropionate 0.05mg/18.7 G
Beklometazon dipropionat 0,05 mg/18,7 G
Budesonide 0,5 Mg
Pulmicort Budesonide Budezonid 0,5 Mg
Fluticasone Propionate 125µg Dose Pressurised Inhalation,
Flutikazon propionat doza od 125 µg Stlačeni inhalat, suspenzija
Formoterol Fumarate Dihydrate 6µg Actuation, Beclometasone Dipropionate Anhydrous 100µg Actuation
Formoterol fumarat dihidrat doza od 6 µg po aktuaciji, beklometazon dipropionat bezvodni 100 µg po aktuaciji
Fluticasonpropionat „allen“ Fluticasone Propionate 250µg Dose Inhalation Powder
Kg Flixotide Forte Diskus Flutikazon propionat doza od 500 µg Prašak inhalata
Fluticasone Propionate 250µg Inhalation, Salmeterol Xinafoate 25µg Inhalation
Flutikazon propionat 250 µg inhalat, salmeterol ksinafoat 25 µg inhalat
Salmeterol Xinafoate 50µg Dose, Fluticasone 250µg Dose
Salmeterol ksinafoat doza od 50 µg, flutikazon doza od 250 µg
Belgium Elpen Pharmaceutical Co. Inc.
Rumunjska Elpen Pharmaceutical Co.
Fluticasone Propionate 250µg Dose Pressurised Inhalation
Flutikazon propionat doza od 250 µg Stlačeni inhalat
Salmeterol Xinafoate 50µg Dose, Fluticasone Propionate 500µg Dose
Salmeterol ksinafoat doza od 50 µg, flutikazon propionat doza od 500 µg
Fluticasone Propionate 500µg Dose Inhalation Powder, Pre-Dispensed
Flutikazon propionat doza od 500 µg Prašak inhalata, dozirani
Fluticasone Propionate 250µg Dose Inhalation Powder, Pre-Dispensed
Flutikazon propionat doza od 250 µg Prašak inhalata, dozirani
Salmeterol 50µg Dose, Fluticasone Propionate 500µg Dose
Salmaterol doza od 50 µg, flutikazon propionat doza od 500 µg
Budesonide 160µg Dose, Formoterol Fumarate Dihydrate Ph.Eur.
Budezonid doza od 160 µg, formoterol fumarat dihidrat Ph.Eur. doza od 4,5 µg
Heumann Pharma Gmbh & Co. Generica Kg
Njemačka Heumann Pharma Gmbh & Co.
Salmeterol Xinafoate 50µg Dose, Fluticasone 500µg Dose
Salmeterol ksinafoat doza od 50 µg, flutikazon doza od 500 µg
Fluticasone Propionate 500µg Inhalation
Flutikazon propionat 500 µg inhalat
Fluticasone Propionate 250µg Dose Pressurised Inhalation,
Flutikazon propionat doza od 250 µg Stlačeni inhalat, suspenzija
Fluticasone Propionate 500µg Inhalation, Salmeterol 50µg Inhalation
Atmadisc Forte Diskus Flutikazon propionat 500 µg inhalat, salmeterol 50 µg inhalat
Below is a list of examples of these types of medicines:
U nastavku se nalazi popis primjera ovih vrsta lijekova:
Important things to be aware of:
Važne stvari kojih morate biti svjesni:
This may take 5-10 minutes.
5-10 minuta.
• Take the dose once a day by placing the tablets under the tongue.
• Uzmite dozu jednom dnevno stavljanjem tableta pod jezik.
Suboxone with food, drink and alcohol
Suboxone s hranom, pićem i alkoholom
You may be unable to think clearly, and may breathe much slower than is normal for you.
Možda nećete moći jasno razmišljati, ili ćete disati puno sporije nego što je uobičajeno.
1 - Do not push the tablet through the foil.
1 - Ne gurajte tabletu kroz foliju.
Date of latest renewal: 26 September 2011
Datum posljednje obnove: 26. rujna 2011.
• recently suffered a head injury or brain disease
• ako ste nedavno zadobili ozljedu glave ili imali bolest mozga
United Kingdom.
Velika Britanija.
These may be signs of a life-threatening allergic reaction.
Ovo mogu biti znakovi životno ugrožavajuće alergijske reakcije.
Use in adolescents (Age 15-<18)
Primjena u adolescenata (dob od 15 do <18)
Acute alcoholism or delirium tremens.
Akutni alkoholizam ili delirium tremens
PK Parameter
PK parametar
What Suboxone is and what it is used for
Što je Suboxone i za što se koristi
Due to the lack of data in adolescents (age 15-<18), patients in this age group should be more closely monitored during treatment.
S obzirom na nedostatak podataka u adolescenata (u dobi od 15 do <18), bolesnici ove dobne skupine moraju se pažljivije pratiti tijekom liječenja.
Therefore, dosages must be limited and this combination must be avoided in cases where there is a risk of misuse.
Zbog toga doze moraju biti ograničene i ta se kombinacija lijekova mora izbjegavati u slučajevima u kojima postoji rizik od zlouporabe.
• some medicines may decrease the effect of Suboxone.
• neki lijekovi mogu smanjiti učinke lijeka Suboxone.
In some patients, after a satisfactory stabilisation has been achieved, the frequency of dosing may be decreased to 3 times a week (for example on Monday, Wednesday and Friday).
U nekih bolesnika učestalost primjene, nakon što je postignuta zadovoljavajuća stabilizacija, može se smanjiti na 3 puta tjedno (na primjer, ponedjeljkom, srijedom i petkom).
Regular blood tests may be conducted by your doctor to monitor the condition of your liver.
Vaš liječnik može provoditi redovite krvne pretrage kako bi nadzirao stanje Vaše jetre.
• Additional monitoring
• Dodatno praćenje
You may be more closely monitored by your doctor if you are below the age of 18 or over the age of 65.
Vaš liječnik će Vas pomnije pratiti ako imate manje od 18 ili više od 65 godina.
Email: PatientSafetyRoW@indivior.com
E-mail PatientSafetyRoW@indivior.com
Suboxone is used in adults and adolescents over 15 years of age, who are also receiving medical, social and psychological support.
Suboxone se koristi u odraslih osoba i adolescenata starijih od 15 godina, koji također primaju medicinsku, socijalnu i psihološku pomoć.
The patient should be transferred to an environment within which full resuscitation facilities are available.
Bolesnika treba premjestiti na odjel gdje postoji kompletna oprema za oživljavanje.
2 - Remove just one section from the blister pack, tearing it along the perforated line.
2 - Odvojite samo jedan odjeljak od blistera, kidajući ga uzduž perforirane linije.
Content of the pack and other Information
Sadržaj pakiranja i druge informacije
No synergistic enhancement of toxicity has been observed.
Nije primjećeno sinergističko pojačanje toksičnosti.
• any liver disease such as hepatitis
• bilo koju bolest jetre poput hepatitisa
This may happen more often in the first few weeks of treatment when your dose is being changed, but can also happen if you drink alcohol or take other sedative medicines when you take Suboxone.
Do ovog može doći češće u prvih nekoliko tjedana liječenja kada Vam se mijenja doza, no također se može pojaviti ako uz Suboxone konzumirate alkohol ili uzimate druge sedative.
• Do not chew or swallow the tablets, as the medicine will not work and you may get withdrawal symptoms.
• Nemojte žvakati ili gutati tablete, jer lijek neće djelovati i možete imati simptome ustezanja.
If you have the impression that the effect of Suboxone is too strong or too weak, talk to your doctor or pharmacist.
Ako imate dojam da je učinak lijeka Suboxone prejak ili preslab, razgovarajte sa svojim liječnikom ili ljekarnikom.
When a hepatic event is suspected, further biological and etiological evaluation is required.
Kad se sumnja na jetreni događaj, potrebna su daljnja biološka i etiološka ispitivanja.
The frequency of possible side effects listed below is defined using the following convention: Very common (1/10), Common (1/100 to <1/10), Uncommon (1/1,000 to <1/100), Not known (cannot be estimated from available data).
Učestalost mogućih nuspojava navedenih u nastavku definirana je na sljedeći način: vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1000 i <1/100), nepoznato (ne može se procijeniti iz dostupnih podataka).
Suboxone can also cause withdrawal symptoms if you stop taking it abruptly.
Suboxone može također uzrokovati simptome ustezanja ako ga naglo prestanete uzimati.
• alcoholic drinks or medicines containing alcohol, as alcohol increases the sedative effect of buprenorphine (see section 4.7).
• alkoholnim pićima ili lijekovima koji sadrže alkohol, jer alkohol pojačava sedativni učinak buprenorfina (vidjeti dio 4.7).
• asthma or other breathing problems
• astmu ili bilo koji drugi problem s disanjem
Suboxone should not be taken together with:
Suboxone ne bi trebalo uzimati zajedno s:
Some medicines may increase the side effects of Suboxone and may sometimes cause very serious reactions.
Neki lijekovi mogu povećati nuspojave lijeka Suboxone te mogu ponekad uzrokovati vrlo ozbiljne reakcije.
Do not take Suboxone together with alcohol.
Ne uzimajte Suboxone zajedno s alkoholom.
Patients with rare hereditary problems of galactose intolerance, should not take this medicine.
Bolesnici s nasljednim problemima netolerancije galaktoze ne bi trebali uzimati ovaj lijek
However, Suboxone can be a target for people who abuse prescription medicine.
Međutim, Suboxone može biti meta osobama koje zloupotrebljavaju lijekove koji se izdaju na recept.
• Misuse and abuse
• Pogrešna uporaba i zlouporaba
Dublin 2
Dublin 2 Irska
Naloxone has a mean half-life from plasma of 1.2 hours.
Nalokson ima srednji poluvijek u plazmi od 1,2 sata.
Therefore, breastfeeding should be discontinued during treatment with Suboxone.
Stoga dojenje treba prekinuti za vrijeme liječenja lijekom Suboxone.
o benzodiazepines: This combination may result in death due to respiratory depression of central origin.
o benzodiazepinima: Ova kombinacija može dovesti do smrti zbog središnje prouzročene depresije disanja.
• a urinary disorder (especially linked to enlarged prostrate in men)
• poremećaj mokrenja (koji je osobito povezan s uvećanom prostatom u muškaraca)
Symptomatic treatment of respiratory depression, and standard intensive care measures, should be implemented.
Treba provesti simptomatsko liječenje respiratorne depresije i standardne mjere intenzivne njege.
Like all medicines, Suboxone can cause side effects, although not everybody gets them.
Kao i svi lijekovi, Suboxone može uzrokovati nuspojave iako se neće javiti kod svakoga.